Lung function and disease activity in sarcoidosis Disease activity in sarcoidosis

Applied Cardiopulmonary Pathophysiology

Volumn 6, Issue 1, 1996, Pages 61-70

  Brådvik, Ingela ^a   Wollmer, Per ^a   Evander, Eva ^a   Sloth, Maja ^a   Lárusdóttir, Hildur ^a   Blom Bülow, Berith ^a   Jonson, Björn ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Exercise testing; Gallium radioisotopes; Inflammation; Lung function measurements; Radionuclide imaging; Technetium 99m pertechnetate

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GALLIUM; PENTETIC ACID; TECHNETIUM 99M;

ADULT; ARTERIAL BLOOD; ARTICLE; BLOOD GAS ANALYSIS; CLINICAL ARTICLE; DISEASE ACTIVITY; FEMALE; HUMAN; LUNG CLEARANCE; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG MECHANICS; LUNG VOLUME; MALE; PRIORITY JOURNAL; SARCOIDOSIS; SCINTISCANNING; SPIROMETRY;

EID: 0029952024     PISSN: 09205268     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 99mTc-DTPA, lung surfactant and lung injury: a review of the literature. Appl Cardiopulm Pathophys 1991; 4: 155-60.
2. 99mTc-DTPA: a noninvasive assessment of epithelial integrity. Lung 1987; 165: 1-16.
3. 99mTc-DTPA in smokers. Clin Physiol 1994; 14: 547-59.
4. Jacobs MP, Baughman RP, Hughes J, Fernandez-Ulloa M. Radioaerosol lung clearance in patients with active pulmonary sarcoidosis. Am Rev Respir Dis 1985; 131: 687-9.
5. -99m labelled dicthylene triamine penta-acetic acid in patients with sarcoidosis and smokers. Eur J Nucl Med 1994; 21: 1218-22.
6. 99mTc-DTPA and pulmonary involvement in sarcoidosis. Am Rev Respir Dis 1986; 134: 493-7.
7. 99mTc-DTPA clearance measured by a dual head gamma camera in healthy subjects and in patients with sarcoidosis. Eur J Nucl Med 1989; 15: 71-7.
8. Fraser RG, Paré JAP. Diseases of the chest of unknown origin. In: Fraser RG, Paré JAP (eds) Diagnosis of diseases of the chest. Philadelphia: Saunders, 1979, pp 1665-78.
9. Jonson B. A method for determination of pulmonary elastic recoil and resistance at a regulated flow rate. Scand J Clin Lab Invest 1969; 24: 115-25.
10. Bradvik I, Wollmer P, Blom-Bülow B, Albrechtsson U, Jonson B. Lung mechanics and gas exchange during exercise in pulmonary sarcoidosis. Chest 1991; 99: 572-8.
11. Jones JG, Minty BD, Lawler P, Hulands G, Crawley JCW, Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1980; 1: 66-8.
12. 99mTc-DTPA: influence of background activity. J Appl Physiol 1988; 64: 1045-9.
13. Nelder JA, Mead R. A simplex method for function minimization. Comput J 1965; 7: 308-13.
14. Dennis Jr JE, Woods DJ. New computing environments: microcomputers in large-scale computing(ed. Wouk A) SIAM 1987; 116-22.
15. 67Ga scintigraphy as an index of disease activity in pulmonary sarcoidosis. Eur J Nucl Med 1981; 6: 205-12.
16. Holmqvist B, Bünning P, Riordan JF. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 1979; 95: 540-8.
17. Berglund E, Birath G, Bjure J, Grimby G, Kjellmer I, Sandqvist L, Söderholm B. Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 1963; 173: 185-92.
18. Grimby G, Söderholm B. Spirometric studies in normal subjects. III. Static lung volumes and maximum voluntary ventilation in adults with a note on physical fitness. Acta Med Scand 1963; 173: 199-206.
19. Jonson B. Pulmonary mechanics in normal men, studied with the flow regulator method. Scand J Clin Lab Invest 1970; 25: 363-73.
20. Knudson RJ, Clark DF, Kennedy TC, Knudson DE. Effects of ageing alone on mechanical properties of the normal adult humanlung. J Appl Physiol: Respirat Environ Exercise Physiol 1978; 43: 1054-62.
21. De Troyer A, Yernault JC. Inspiratory muscle force in normal subjects and in patients with interstitial lung disease. Thorax 1980; 35: 92-100.
22. Nordenfelt I, Adolfsson L, Nilsson JE, Olsson S. Reference values for exercise tests with continuous increase in load. Clin Physiol 1985; 5: 161-72.
23. Astrand I. Aerobic work capacity in men and women with special reference to age. Acta Physiol Scand 1960; Suppl 169: 1-92.
24. Malmberg P, Hedenström H, Fridriksson HB. Reference values for gas exchange during exercise in healthy nonsmoking and smoking men. Bull Eur Physiopathol Respir 1987; 23: 131-8.
25. Bradvik I, Wollmer P, Simonsson B, Albrectsson U, Lyttkens K, Jonson B. Lung mechanics and their relationship to lung volumes in pulmonary sarcoidosis. Eur Respir J 1989; 2: 643-51.
26. 67Gallium scanning in patients with pulmonary sarcoidosis. Sarcoidosis Suppl 1; 1992; 9: 411-2.
27. 67Ga lung scans in assessing sarcoidosis. Experience in 14 research centers in seven different countries. Ann NY Acad Sci 1986; 465: 463-78.
28. Abe S, Munakata M, Nishimura M, Tsuneta Y, Terai T, Nakano I, Ohsaki Y, Kawakami Y. Gallium-67 scintigraphy, bronchoalveolar lavage and pathologic changes in patients with pulmonary sarcoidosis. Chest 1984; 85: 650-5.
29. Line BR, Hunninghake GW, Keogh BA, Jones AE, Johnston GS, Crystal RG. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am Rev Respir Dis 1981; 123: 440-6.
30. Gupta RG, Bekerman C, Sicilian L, Oparil S, Pinsky SM, Szidon JP. Gallium 67 citrate scanning and serum angiotensin converting enzyme levels in sarcoidosis. Radiology 1982; 144: 895-9.
31. 67Gallium scintigraphy, serum ACE levels, chest roentgenography, and blood lymphocyte subpopulations. Chest 1982; 82: 732-8.
32. Holliger WM, Staton Jr GW, Fajman WA, Gilman MJ, Pine JR, Check LT. Prediction of therapeutic response in steroid-treated pulmonary sarcoidosis. Evaluation of clinical parameters, bronchoalveolar lavage, gallium-67 scanning, and serum angiotensin-converting enzyme levels. Am Rev Respir Dis 1985; 132: 65-9.
33. 67Ga scintigraphy in relation to carbon monoxide diffusion capacity in pulmonary sarcoidosis. Sarcoidosis 1993; 10: 36-40.
34. Wallaert B, Cardot E, Colombel J-F, Tonnel A-B. Subclinical immune and inflammatory processes of the mucosal system in sarcoidosis and Crohn's disease. Sarcoidosis Suppl 1; 1992; 9: 215-8.
35. 99mTc-DTPA in patients with sarcoidosis. Ann NY Acad Sci 1986; 465: 33-40.
36. 99mTc-DTPA. Am Rev Respir Dis 1990; 141: 445-9.
37. 99mTc-labeled diethylene-triamine pentaacetate aerosol. Am Rev Respir Dis 1992; 146: 47-52.
38. 99mTc-DTPA in pigeon fancier's hypersensitivity pneumonitis. Am Rev Respir Dis 1990; 142: 1168-71.